SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-20-007997
Filing Date
2020-04-20
Accepted
2020-04-20 07:30:21
Documents
8
Period of Report
2020-06-02
Effectiveness Date
2020-04-20

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A dmtp20200413_def14a.htm DEF 14A 688699
2 chart1.jpg GRAPHIC 578183
3 chart2.jpg GRAPHIC 20239
4 dmtp20200413_def14aimg001.gif GRAPHIC 4731
5 dmtp20200413_def14aimg002.gif GRAPHIC 2043
6 dmtp20200413_def14aimg004.gif GRAPHIC 2016
7 pc01.jpg GRAPHIC 177827
8 pc02.jpg GRAPHIC 208615
  Complete submission text file 0001437749-20-007997.txt   2054610
Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36291 | Film No.: 20801252
SIC: 2834 Pharmaceutical Preparations